Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE POINT OF CARE TESTING (POCT) MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 EUROPE POINT OF CARE TESTING (POCT) MARKET: SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 MULTIVARIATE MODELLING
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES MODEL
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 INCREASING PREVALENCE OF INFECTIOUS AND CHRONIC DISEASES
5.1.2 IMPROVED DIAGNOSIS-SEEKING RATE
5.1.3 DEMAND FOR WEARABLE OR PORTABLE GLUCOSE MONITORING DEVICES
5.1.4 RISING PREFERENCE FOR HOMECARE TESTING
5.2 RESTRAINTS
5.2.1 LACK OF ACCURACY
5.2.2 HIGH COST OF PRODUCT
5.2.3 LACK OF TRAINING
5.3 OPPORTUNITIES
5.3.1 STRATEGIC INITIATIVES BY THE MARKET PLAYERS
5.3.2 RISING AWARENESS AND GOVERNMENT FUNDING
5.4 CHALLENGES
5.4.1 LACK OF ALIGNMENT WITH TEST RESULTS OBTAINED FROM LABORATORIES
5.4.2 IMPROPER CARE OF POCT DEVICES
6 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT
6.1 OVERVIEW
6.2 INSTRUMENTS
6.2.1 MOBILE PLATFORM (SMALL)
6.2.2 FACILITY-BASED PLATFORMS (LARGE POCT PLATFORM)
6.3 CONSUMABLES & REAGENTS
6.4 OTHERS
7 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 BLOOD GLUCOSE
7.3 INFECTIOUS DISEASE TESTING
7.4 CARDIAC MONITORING
7.5 COAGULATION
7.6 WHOLE BLOOD ANALYSIS
7.7 CHOLESTEROL TESTING
7.8 VITAL SIGN MONITORING
7.9 URINE ANALYSIS
7.1 OTHERS
8 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY END USER
8.1 OVERVIEW
8.2 LABORATORIES
8.3 HOSPITALS
8.4 CLINICS
8.5 HOMECARE
8.6 AMBULATORY CENTERS
8.7 ASSISTED LIVING FACILITIES
8.8 PHARMACIES/DRUG STORES
8.9 OTHERS
9 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING
9.1 OVERVIEW
9.2 PRESCRIPTION BASED TESTING
9.3 OTC TESTING
10 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 THIRD PARTY DISTRIBUTOR
10.3 DIRECT SALES
10.4 ONLINE SALES
11 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY COUNTRY
11.1 GERMANY
11.2 U.K.
11.3 FRANCE
11.4 SPAIN
11.5 ITALY
11.6 RUSSIA
11.7 NETHERLANDS
11.8 SWITZERLAND
11.9 TURKEY
11.1 BELGIUM
11.11 REST OF EUROPE
12 EUROPE POINT OF CARE TESTING (POCT) MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: EUROPE
13 SWOT ANALYSIS
14 COMPANY PROFILE
14.1 F. HOFFMANN-LA ROCHE LTD
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 PRODUCT PORTFOLIO
14.1.4 RECENT DEVELOPMENTS
14.2 SIEMENS HEALTHCARE GMBH
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 PRODUCT PORTFOLIO
14.2.4 RECENT DEVELOPMENTS
14.3 WERFEN
14.3.1 COMPANY SNAPSHOT
14.3.2 PRODUCT PORTFOLIO
14.3.3 RECENT DEVELOPMENT
14.4 SYSMEX EUROPE SE.
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 PRODUCT PORTFOLIO
14.4.4 RECENT DEVELOPMENTS
14.5 DANAHER
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 PRODUCT PORTFOLIO
14.5.4 RECENT DEVELOPMENTS
14.6 QUIDEL CORPORATION
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 PRODUCT PORTFOLIO
14.6.4 RECENT DEVELOPMENTS
14.7 LUMIRAXDX
14.7.1 COMPANY SNAPSHOT
14.7.2 REVENUE ANALYSIS
14.7.3 PRODUCT PORTFOLIO
14.7.4 RECENT DEVELOPMENTS
14.8 BD
14.8.1 COMPANY SNAPSHOT
14.8.2 REVENUE ANALYSIS
14.8.3 PRODUCT PORTFOLIO
14.8.4 RECENT DEVELOPMENTS
14.9 ABBOTT
14.9.1 COMPANY SNAPSHOT
14.9.2 REVENUE ANALYSIS
14.9.3 PRODUCT PORTFOLIO
14.9.4 RECENT DEVELOPMENTS
14.1 ABAXIS
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENT
14.11 BINX HEALTH, INC.
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENTS
14.12 CHEMBIO DIAGNOSTICS SYSTEMS, INC
14.12.1 COMPANY SNAPSHOT
14.12.2 REVENUE ANALYSIS
14.12.3 PRODUCT PORTFOLIO
14.12.4 RECENT DEVELOPMENTS
14.13 EKF DIAGNOSTICS
14.13.1 COMPANY SNAPSHOT
14.13.2 REVENUE ANALYSIS
14.13.3 PRODUCT PORTFOLIO
14.13.4 RECENT DEVELOPMENTS
14.14 NOVA BIOMEDICAL
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENTS
14.15 PTS DIAGNOSTICS
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENTS
14.16 SEKISUI DIAGNOSTICS
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENT
14.17 TRINITY BIOTECH
14.17.1 COMPANY SNAPSHOT
14.17.2 REVENUE ANALYSIS
14.17.3 PRODUCT PORTFOLIO
14.17.4 RECENT DEVELOPMENTS
14.18 TRIVIDIA HEALTH, INC.
14.18.1 PRODUCT PORTFOLIO
14.18.2 RECENT DEVELOPMENT
14.19 THERMO FISHER SCIENTIFIC INC. (2021)
14.19.1 COMPANY SNAPSHOT
14.19.2 REVENUE ANALYSIS
14.19.3 PRODUCT PORTFOLIO
14.19.4 RECENT DEVELOPMENTS
14.2 QUANTUMDX GROUP LTD.
14.20.1 COMPANY SNAPSHOT
14.20.2 PRODUCT PORTFOLIO
14.20.3 RECENT DEVELOPMENT
15 QUESTIONNAIRE
16 RELATED REPORTS
List of Table
TABLE 1 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 2 EUROPE INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 3 EUROPE INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY VOLUME, 2020-2029 (MILLION UNITS)
TABLE 4 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 5 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 6 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 7 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 8 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 9 GERMANY POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 10 GERMANY INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 11 GERMANY POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 12 GERMANY POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 13 GERMANY POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 14 GERMANY POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 15 U.K. POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 16 U.K. INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 17 U.K. POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 18 U.K. POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 19 U.K. POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 20 U.K. POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 21 FRANCE POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 22 FRANCE INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 23 FRANCE POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 24 FRANCE POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 25 FRANCE POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 26 FRANCE POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 27 SPAIN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 28 SPAIN INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 29 SPAIN POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 30 SPAIN POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 31 SPAIN POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 32 SPAIN POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 33 ITALY POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 34 ITALY INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 35 ITALY POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 36 ITALY POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 37 ITALY POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 38 ITALY POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 39 RUSSIA POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 40 RUSSIA INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 41 RUSSIA POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 42 RUSSIA POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 43 RUSSIA POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 44 RUSSIA POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 45 NETHERLANDS POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 46 NETHERLANDS INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 47 NETHERLANDS POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 48 NETHERLANDS POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 49 NETHERLANDS POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 50 NETHERLANDS POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 51 SWITZERLAND POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 52 SWITZERLAND INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 53 SWITZERLAND POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 54 SWITZERLAND POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 55 SWITZERLAND POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 56 SWITZERLAND POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 57 TURKEY POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 58 TURKEY INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 59 TURKEY POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 60 TURKEY POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 61 TURKEY POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 62 TURKEY POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 63 BELGIUM POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 64 BELGIUM INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 65 BELGIUM POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 66 BELGIUM POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 67 BELGIUM POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 68 BELGIUM POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 69 REST OF EUROPE POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
List of Figure
FIGURE 1 EUROPE POINT OF CARE TESTING (POCT) MARKET: SEGMENTATION
FIGURE 2 EUROPE POINT OF CARE TESTING (POCT) MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE POINT OF CARE TESTING (POCT) MARKET: DROC ANALYSIS
FIGURE 4 EUROPE POINT OF CARE TESTING (POCT) MARKET: GLOBAL VS REGIONAL ANALYSIS
FIGURE 5 EUROPE POINT OF CARE TESTING (POCT) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE POINT OF CARE TESTING (POCT) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE POINT OF CARE TESTING (POCT) MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE POINT OF CARE TESTING (POCT) MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 EUROPE POINT OF CARE TESTING (POCT) MARKET: SEGMENTATION
FIGURE 10 RISING POPULARITY AMONG PROFESSIONAL ATHLETES IS EXPECTED TO DRIVE THE EUROPE POINT OF CARE TESTING (POCT) MARKET IN THE FORECAST PERIOD OF 2021 TO 2029
FIGURE 11 INSTRUMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE POINT OF CARE TESTING (POCT) MARKET IN 2021 & 2029
FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE POINT OF CARE TESTING MARKET
FIGURE 13 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY PRODUCT, 2021
FIGURE 14 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY PRODUCT, 2022-2029 (USD MILLION)
FIGURE 15 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY PRODUCT, CAGR (2022-2029)
FIGURE 16 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY PRODUCT, LIFELINE CURVE
FIGURE 17 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY APPLICATION, 2021
FIGURE 18 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY APPLICATION, 2022-2029 (USD MILLION)
FIGURE 19 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY APPLICATION, CAGR (2022-2029)
FIGURE 20 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY APPLICATION, LIFELINE CURVE
FIGURE 21 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY END USER, 2021
FIGURE 22 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY END USER, 2022-2029 (USD MILLION)
FIGURE 23 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY END USER, CAGR (2022-2029)
FIGURE 24 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY END USER, LIFELINE CURVE
FIGURE 25 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY MODE OF TESTING, 2021
FIGURE 26 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY MODE OF TESTING, 2022-2029 (USD MILLION)
FIGURE 27 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY MODE OF TESTING, CAGR (2022-2029)
FIGURE 28 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY MODE OF TESTING, LIFELINE CURVE
FIGURE 29 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY DISTRIBUTION CHANNEL, 2021
FIGURE 30 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 31 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 32 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 33 EUROPE POINT OF CARE TESTING (POCT) MARKET : SNAPSHOT (2021)
FIGURE 34 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY COUNTRY (2021)
FIGURE 35 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY COUNTRY (2022 & 2029)
FIGURE 36 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY COUNTRY (2021 & 2029)
FIGURE 37 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY PRODUCT (2022 & 2029)
FIGURE 38 EUROPE POINT OF CARE (POCT) MARKET: COMPANY SHARE 2021 (%)
